Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence

NCT03489265 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Difficult to recruit severely affected patients with fecal incontinence

Conditions

Fecal Incontinence
Accidental Bowel Leakage
Anal Incontinence
Diarrhea
Urge Incontinence

Interventions

DRUG: Eluxadoline 100 mg
OTHER: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]